Search Results - "Pagnano, K B B"

P396: DYSREGULATED DNAM‐1 AND KIR2DL1 EXPRESSION IN NATURAL KILLER CELLS CORRELATES WITH POOR OUTCOME IN ACUTE MYELOID LEUKEMIA by F O Costa, A., O Marani, L., A Lopes, I., S Binelli, L., S Scheucher, P., L S Schiavinato, J., A Madeira, M. I., B B Pagnano, K., K Duarte, B., F Glória, A. B., M Rego, E., Traina, F., Welner, R., L Figueiredo‐Pontes, L.

Get full text

PB1814: RARE PHENOTYPE WITH CD33 ABSENT IN ACUTE MYELOID LEUKEMIA MIMICKING MRD POSITIVITY: A CASE REPORT by O Marani, L., Costa, A., B Silva, F., A Madeira, M. I., S Scheucher, P., L S Schiavinato, J., G Lima, A. S., B B Pagnano, K., K Duarte, B., Freeman, S., M Rego, E., Traina, F., L Figueiredo‐Pontes, L.

Get full text

Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage by da Costa Reis Monte-Mór, B, Plo, I, da Cunha, A F, Costa, G G L, de Albuquerque, D M, Jedidi, A, Villeval, J-L, Badaoui, S, Lorand-Metze, I, Pagnano, K B B, Saad, S T O, Vainchenker, W, Costa, F F

“…The JAK2 V617F mutation, present in the majority of polycythemia vera (PV) patients, causes constitutive activation of JAK2 and seems to be responsible for the…”
Get full text

Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia by Rossini, MS, De Souza, EM, Cintra, ML, Pagnano, KB, Chiari, AC, Lorand-Metze, I

“…ABSTRACT Introduction  2‐Chlorodeoxyadenosine (cladribine or 2‐CdA) is a purine analogue that has been used successfully in hairy cell leukaemia (HCL)…”
Get full text

JAK2 46/1 haplotype is associated with JAK2 V617F - positive myeloproliferative neoplasms in Brazilian patients by Macedo, L. C., Santos, B. C., Pagliarini-e-Silva, S., Pagnano, K. B. B., Rodrigues, C., Quintero, F. C., Ferreira, M. E., Baraldi, E. C., Ambrosio-Albuquerque, E. P., Sell, A. M., Visentainer, J. E. L.

“…Summary Introduction This study aimed to verify the association between the JAK2 46/1 haplotype (V617F positive) and some hematological parameters in…”
Get full text

AVALIAÇÃO DAS ALTERAÇÕES CITOGENÉTICAS ADICIONAIS AO DIAGNÓSTICO EM UMA COORTE DE PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA TRATADOS COM IMATINIBE GENÉRICO by GEAA Santos, EG Emiliano, E Miranda, GO Duarte, G Duffles, NN Gonçalves, GH Magalhães, N Clementino, FS Seguro, I Bendit, IM Toni, GC Furlin, M Zocca, R Oliveira, PM Campos, C Souza, M Conchon, KB Pagnano

“…Objetivos: Avaliar a frequência e as anormalidades cromossômicas adicionais (ACA) ao diagnóstico em coorte de pacientes com LMC tratados com imatinibe genérico…”
Get full text

Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas by Pagnano, K B B, Silva, M D, Vassallo, J, Aranha, F J P, Saad, Sara T O

“…We evaluated the expression of apoptosis-regulating proteins (p53, Bcl-2, Bax, Bak and Mcl-1) in paraffin-embedded tissues of 33 patients with diffuse large B…”
Get more information

Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience by Pagnano, K B, Traina, F, Takahashi, T, Oliveira, G B, Rossini, M S, Lorand-Metze, I, Vigorito, A C, Miranda, E C, De Souza, C A

“…Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) using conventional chemotherapy in about 55-85%. However, 30% of…”
Get full text

Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines by Jacomo, Rafael Henriques, Melo, Raul Antonio Morais, Souto, Fernanda Ribeiro, de Mattos, Ederson Roberto, de Oliveira, Claudia Teresa, Fagundes, Evandro M, Bittencourt, Henrique Neves da Silva, Bittencourt, Rosane Isabel, Bortolheiro, Teresa Cristina, Paton, Eduardo J.A, Bendlin, Rodrigo, Ismael, Sebastiao, de Lourdes Chauffaille, Maria, Silva, Dirceu, Pagnano, Katia Borgia B, Ribeiro, Raul, Rego, Eduardo M

“…1 Department of Internal Medicine, Medical School of Ribeirao Preto, Brazil; 2 Molecular Biology Laboratory, HEMOPE, Brazil; 3 Bone Marrow Transplantation…”
Get full text

JAK2 46/1 haplotype is associated with JAK 2 V617F – positive myeloproliferative neoplasms in Brazilian patients by Macedo, L. C., Santos, B. C., Pagliarini‐e‐Silva, S., Pagnano, K. B. B., Rodrigues, C., Quintero, F. C., Ferreira, M. E., Baraldi, E. C., Ambrosio‐Albuquerque, E. P., Sell, A. M., Visentainer, J. E. L.

“…Summary Introduction This study aimed to verify the association between the JAK 2 46/1 haplotype (V617F positive) and some hematological parameters in BCR ‐…”
Get full text

Evaluación de la respuesta hematológica, citogenética, molecular y a la resistencia al Imatinib by K. B. Pagnano

“…El mesilato de imatinib se considera la mejor drogra para el tratamiento de la Leucemia Mielóide Crónica (LMC)…”
Get full text

p53, Mdm2, and c‐Myc overexpression is associated with a poor prognosis in aggressive non‐Hodgkin's lymphomas by Pagnano, Katia B.B., Vassallo, Jose, Lorand‐Metze, Irene, Costa, Fernando F., Saad, Sara T.O.

“…The expression of p53, p21/WAF‐1, Mdm2, c‐Myc, and proliferating cell nuclear antigen (PCNA) proteins was examined by the immunohistochemistry of…”
Get full text

Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report by Baldissera, R C, Nucci, M, Vigorito, A C, Maiolino, A, Simões, B P, Lorand-Metze, I, Aranha, F J P, Miranda, E C M, Pagnano, K B B, Ruiz, M A, Moraes, A A J G, De Souza, C A

“…This prospective multicenter randomized trial compares conventional with early intensification with high-dose sequential chemotherapy (HDS) and autologous stem…”
Get more information

Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma by Duarte, Bruno K.L., Valente, Isabella, Vigorito, Afonso C., Aranha, Francisco J.P., Oliveira-Duarte, Gislaine, Miranda, Eliana C.M., Lorand-Metze, Irene, Pagnano, Katia B., Delamain, Marcia, Marques Junior, José F., Brandalise, Silvia R., Nucci, Márcio, De Souza, Carmino A.

“…We evaluate the effectiveness and toxicity of high-dose sequential chemotherapy (HDS) as salvage therapy in patients with advanced-stage Hodgkin lymphoma. We…”
Get full text

Tratamiento y seguimiento en pacientes con leucemia mieloide crónica en el hemocentro - UNICAMP (Brasil) by E. Miranda, M. Torresan Delamain, I. Lorand Metze, A. C. Vigorito, K. B. Pagnano, C. A. de Souza

“…Relatar la experiencia del Hemocentro Unicamp en el tratamiento y seguimiento de los pacientes con leucemia mieloide crónica (LMC) tratados con mesilato de…”
Get full text

Expression of p190 BCR-ABL fusion gene in a patient with chronic myeloid leukemia by Carvalho, P. V. B., Lourenço, Gustavo J., Zocca, Maristela, Pagnano, K. B. B., Lorand-Metze, Irene, Souza, Carmino A. De, Lima, Carmen S. P.

“…A minority of chronic myeloid leukemia cases have breakpoints in the minor cluster region (m-bcr) of the BCR-ABL gene. We report on a patient with Ph-positive…”
Get full text

Philadelphia-negative chronic myeloproliferative neoplasms by Bittencourt, Rosane Isabel, Vassallo, Jose, Chauffaille, Maria de Lourdes Lopes Ferrari, Xavier, Sandra Guerra, Pagnano, Katia Borgia, Nascimento, Ana Clara Kneese, De Souza, Carmino Antonio, Chiattone, Carlos Sergio

“…Chronic myeloproliferative diseases without the Philadelphia chromosome marker (Ph-), although first described 60 years ago, only became the subject of…”
Get full text

Expression of p190 BCR-ABL fusion gene in a patient with chronic myeloid leukemia Expressão do rearranjo gênico BCR-ABL com ponto de quebra na região menor do gene BCR em um paciente com leucemia mielóide crônica by P. V. B. Carvalho, Gustavo J. Lourenço, Maristela Zocca, K. B. B. Pagnano, Irene Lorand-Metze, Carmino A. De Souza, Carmen S. P. Lima

“…A minority of chronic myeloid leukemia cases have breakpoints in the minor cluster region (m-bcr) of the BCR-ABL gene. We report on a patient with Ph-positive…”
Get full text